SalvaRx Group plc announced earnings results for the half year ended June 30, 2019. For the half year, the company announced total revenue was GBP 64.499 million compared to GBP 0 a year ago. Operating income was GBP 61.304 million compared to operating loss of GBP 190,000 a year ago. Net income was GBP 61.277 million compared to net loss of GBP 190,000 a year ago. Basic earnings per share was GBP 1.67 compared to basic loss per share of GBP 0.005 a year ago.